| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR PUT | 100,000 | 20,585,000 | 6.49% | Put | |
| 2 | ULTRAGENYX PHARMACEUTICAL INC COM | 200,000 | 20,478,000 | 6.46% | ||
| 3 | CELGENE CORP | 150,000 | 17,360,000 | 5.48% | ||
| 4 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 200,000 | 14,878,000 | 4.69% | Put | |
| 5 | PFIZER INC | 400,000 | 13,412,000 | 4.23% | Call | |
| 6 | Esperion Therapeutics Inc | 150,000 | 12,264,000 | 3.87% | ||
| 7 | GILEAD SCIENCES INC | 100,000 | 11,708,000 | 3.69% | ||
| 8 | AMGEN INC | 60,000 | 9,211,000 | 2.91% | ||
| 9 | EXPRESS SCRIPTS HLDG CO | 100,000 | 8,894,000 | 2.81% | ||
| 10 | ANTHEM INC | 50,000 | 8,207,000 | 2.59% | ||
| 11 | VALEANT PHARMACEUTICALS INTL | 35,000 | 7,775,000 | 2.45% | ||
| 12 | MEDTRONIC PLC | 100,000 | 7,410,000 | 2.34% | ||
| 13 | ST JUDE | 100,000 | 7,307,000 | 2.31% | ||
| 14 | ACCELERATE DIAGNOSTICS INC | 270,000 | 6,969,000 | 2.20% | ||
| 15 | HORIZON PHARMA PLC | 200,000 | 6,948,000 | 2.19% | ||
| 16 | PFIZER INC | 200,000 | 6,706,000 | 2.12% | ||
| 17 | CIGNA CORPORATION | 40,000 | 6,480,000 | 2.04% | ||
| 18 | AETNA INC NEW | 50,000 | 6,373,000 | 2.01% | Call | |
| 19 | BIOGEN INC | 15,000 | 6,059,000 | 1.91% | ||
| 20 | IMPAX LABORATORIES INC | 125,000 | 5,740,000 | 1.81% | ||
| 21 | GW PHARMACEUTICALS PLC | 45,000 | 5,528,000 | 1.74% | ||
| 22 | MYLAN N V | 75,000 | 5,090,000 | 1.61% | ||
| 23 | EDWARDS LIFESCIENCES CORP | 35,000 | 4,985,000 | 1.57% | ||
| 24 | ABBOTT LABS | 100,000 | 4,908,000 | 1.55% | Call | |
| 25 | NOVADAQ TECHNOLOGIES INC | 400,000 | 4,844,000 | 1.53% | ||
| 26 | ACCELERON PHARMA | 150,000 | 4,746,000 | 1.50% | ||
| 27 | SUPERNUS PHARMACEUTICALS INC COM | 265,000 | 4,500,000 | 1.42% | ||
| 28 | TEVA PHARMACEUTICAL INDS LTD | 75,000 | 4,433,000 | 1.40% | ||
| 29 | IPC THE HOSPITALIST CO | 75,000 | 4,154,000 | 1.31% | ||
| 30 | WRIGHT MEDICAL GROUP N.V. | 150,000 | 3,749,000 | 1.18% | ||
| 31 | ALLSCRIPTS HEALTHCARE | 250,000 | 3,420,000 | 1.08% | ||
| 32 | ASSEMBLY BIOSCIENCES INC | 175,000 | 3,371,000 | 1.06% | ||
| 33 | IMMUNE DESIGN CORP COM | 150,000 | 3,098,000 | 0.98% | ||
| 34 | ENDOLOGIX INC | 200,000 | 3,068,000 | 0.97% | ||
| 35 | ARATANA THERAPEUTICS INC COM | 200,000 | 3,024,000 | 0.95% | ||
| 36 | IONIS PHARMACEUTICAL | 50,000 | 2,878,000 | 0.91% | ||
| 37 | AGIOS PHARMACEUTICALS INC | 25,000 | 2,779,000 | 0.88% | Put | |
| 38 | DBV TECHNOLOGIES | 90,000 | 2,680,000 | 0.85% | ||
| 39 | WRIGHT MEDICAL GROUP NV | 100,000 | 2,626,000 | 0.83% | ||
| 40 | HEALTH NET INC | 40,000 | 2,565,000 | 0.81% | Call | |
| 41 | TETRAPHASE PHARMACEUTICALS I COM | 50,000 | 2,372,000 | 0.75% | ||
| 42 | NUVASIVE INC COM | 50,000 | 2,369,000 | 0.75% | ||
| 43 | APPLIED GENETIC TECHNOL CORP | 150,000 | 2,301,000 | 0.73% | ||
| 44 | IGNYTA INC COM | 150,000 | 2,264,000 | 0.71% | ||
| 45 | ONCOMED PHARMACEUTICALS INC | 100,000 | 2,250,000 | 0.71% | ||
| 46 | ENDO INTL | 25,000 | 1,991,000 | 0.63% | ||
| 47 | CELLDEX THERAPEUTICS INC NEW | 75,000 | 1,892,000 | 0.60% | ||
| 48 | PACIFIC BIOSCIENCES CALIF IN | 275,000 | 1,584,000 | 0.50% | ||
| 49 | EPIZYME INC COM | 65,000 | 1,560,000 | 0.49% | ||
| 50 | KITE PHARMA INCORPORATED | 25,000 | 1,524,000 | 0.48% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-15-000012, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
